VisionGate has developed an in-vitro, cell characterization platform technology. This patented, breakthrough system, the Cell-CT™, generates high resolution true 3D information from intact cells for the automated analysis of biomarkers

For applications outside of research, the Cell-CT is considered an investigational device that is under development; the Cell-CT has not been cleared by the FDA or other regulatory agencies for any applications.

Cell-CT Platform produces true 3D images of intact cells

VisionGate’s Cell-CT platform produces high resolution 3D information for automated analysis of intact cells. Cells are injected into a capillary tube that rotates to allow image capture at multiple viewing angles to compute the internal 3D structure, thus enabling spatially defined densitometry of labeled molecular species and nuclear chromatin.

Shown at left is a squamous cancer cell from the lung with the cell cytoplasm in translucent white, the nucleus in opaque blue, interior nucleoplasm in translucent green and nucleoli in opaque red.

Watch 3D videos of various cell types produced by the Cell-CT.

View Videos

• May 1, 2008:

  Swedish Cancer Institute Taking Part in Development of Cell-CT™ Platform for Lung Cancer Risk Assessment

• April 9, 2008:

  VisionGate Selects MathStar to Help Deliver Innovative Cell-CT™ Cellular Characterization Platform